Top 15 Global MedTech Firms Undergo Leadership Overhaul in Early 2026 Amid Strategic Restructuring and Capital Shifts

May 31, 2026 19:01 CST Updated 19:01

Hologic

Developer of Medical Imaging Systems and Diagnostic and Surgical Products

Medtronic

Medical Device Manufacturer

Integra

Telecommunications and network service providers

Viatris

Generic Drug Manufacturer

Teleflex

Supplier of disposable medical products, surgical instruments, and medical devices

Device Home

Pioneer in Medical Device Media Coverage

Sharing Professional Medical Device Knowledge

Source:Device Home,No reposting without authorization; reposting is permitted only after 24 hours.

Since the beginning of 2026, the global medical technology industry has experienced a rare wave of intensive senior executive adjustments. According toIncompleteStatistics，As ofBy mid-May, 15 medical technology companies had announced significant executive changes at the Chief Executive Officer (CEO) or Chief Financial Officer (CFO) level.Industry insiders point out that behind this wave of executive changes lies a strategic choice driven by multiple factors, including companies’ pursuit of new capital injection, restructuring of product portfolios, and response to market growth pressures.

Overview of Executive Changes at Major Companies in 2026 (January–May)

This round of executive adjustments covered multiple listed companies, ranging from industry giants to niche market leaders, presentingA landscape characterized by the parallel trends of “veteran executives returning” and “cross-industry poaching.” Among these, the year’s largest deal—Hologic’s $18.3 billion privatization accompanied by a simultaneous leadership change—has drawn particular attention. The following are the year’sPartSummary of Key Personnel Changes:

Time	Company	Position	Newly Appointed/Former Executive	Background/ Remarks
May 19	Medtronic	Department Head	Kweli Thompson (Promotion)	Appointed as Head of the Neuroscience Department, Internal Promotion
May 19	BD	Executive	Peter Menziuso(Newly Appointed)	JoinBD Interventional Business Segment
May 11	BD	CFO	Vitor Rocha (New, Permanent)	Internal Promotion: Previously an External Candidate, Formal Appointment
May 6	Integra	CEO	Stuart Essig (Regression)	FrontCEO, succeeding Mo Jie Paul, whose tenure was less than 18 months, in the "veteran returns" model
May 5	Edwards	CFO	Theodora Mistras(Newly Appointed)	Pharmaceutical CompanyFormer CFO of Viatris, with investment banking experience
April 30	Teleflex	CEO	Jason Weidman(Newly Appointed)	Medtronic20-Year Veteran Assists in Reshaping Portfolio While Divesting Three Businesses
April 28	Zimmer Biomet	CFO	Suketu Upadhyay (Resignation)	Transferred to a Biopharmaceutical CompanyIncyte: Paul Stellato Temporarily Assumes Role of CFO
April 8	Hologic	CEO	José Almeida(Newly Appointed)	Former BaxterCEO, Facilitates Completion of $18.3 Billion Privatization Transaction
April 6	Hologic	CEO	Steve MacMillan(Resignation)	Ren Zhichao12 Years Later, Retirement: Blackstone and TPG Complete $18.3 Billion Acquisition, Taking the Company Private
March 18	Field Medical	CEO	Mark Turco(Newly Appointed)	Interventional Cardiologist, FormerCEO of JC Medical, Chief Medical Officer of Medtronic’s Aortic and Peripheral Vascular Business
March 18	Baxter	CFO	Joel Grade(Leaving Office)	Tenure of two years, during which the company divested its Renal Care Unit
March 16	Grail	CEO	Bob Ragusa(Retired)	President Josh·Hoffmann takes over; analysts say it is unrelated to NHS trial results
March 11	Coloplast	CEO	Gavin Wood(Newly Appointed)	Former Johnson & JohnsonChairman of the EMEA Medical Technology Business Group, with a 20-year tenure
February 3	STAAR Surgical	CEO	Warren FoustandDeborah Andrews	Two TemporaryCEO Takes Office; Former CEO Resigns After Shareholders Reject Alcon’s $1.6 Billion Acquisition, Permanent Successor Sought
January 29	Cleveland Diagnostics	CEO	Michael Iskra(Newly Appointed)	PromoteCommercialization of the IsoPSA Blood Test for Prostate Cancer
January 21	BVI	CEO	Jim Hollingshead(Newly Appointed)	FrontInsulet CEO Expands Global Ophthalmology Business with $1 Billion Financing
January 16	STAAR Surgical	CEO	Stephen Farrell(Resignation)	Activist Investors Push for Board Restructuring Before Departure; Shareholders onJanuary: Rejection of Alcon’s $1.6 Billion Acquisition Offer
January 13	Inspire	CFO	Matt Osberg(Newly Appointed)	No experience in the medical technology industry,CEO Says It Can Help the Company "Reach New Heights"
January 9	Teleflex	CEO	Stuart Randall(Leaving Office)	After retiring in 2018, he once served as an interim successor; Liam Kelly had temporarily taken over.

The Common Logic Behind the Transformation

In summary,Executive Turnover in the Medical Technology Industry in 2026 Shows Three Major Trends:

Privatization-Driven Leadership Change: byRepresented by Hologic, the completion of the $18.3 billion privatization transaction saw new investors bring in external leaders with extensive experience in operating and integrating large enterprises, marking the deep involvement of private equity capital in leading medical device companies.

CFO Role Upgrade：The CFO appointments at companies such as Edwards, BD, and Zimmer Biomet have all emphasized financial strategy and capital operations capabilities, reflecting the industry’s heightened expectations for financial leadership amid changing financing conditions.

Accelerated Cross-Industry Talent Mobility: From pharmaceutical (from Viatris and biotech firm Incyte to the consumer health sector, executives are being recruited by medical device companies, with talent boundaries becoming increasingly blurred.

A partner in McKinsey’s Medical Technology practice recently pointed out in a research report:"2026 will be a pivotal year for the medical device industry's 'talent-for-strategy' shift."。The stability of leadership will directly determine whether a company can strike a balance between reshaping its product portfolio and enhancing capital efficiency."

END

Content Communication / Business Cooperation:18015541606

BusinessBusiness Cooperation Email: qxzj@landianyiliao.com